Over the past 12 months, 0 insiders at INVO Bioscience, Inc. filed 0 open-market SEC Form 4 transactions on INVO: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 22 | Michael Jos. CampbellChief Operating Officer | BUY | 10.5K | $0.95 | $10K |
| Jun 1, 22 | Trent D DavisDirector | BUY | 11.2K | $0.95 | $11K |
| Jun 1, 22 | Kevin DoodyMedical Director | BUY | 177.3K | $0.95 | $168K |
| Jun 1, 22 | Andrea GorenChief Financial Officer | BUY | 52.6K | $0.95 | $50K |
| Jun 1, 22 | Rebecca MessinaDirector | BUY | 9.9K | $0.95 | $9K |
| Jun 1, 22 | Barbara RyanDirector | BUY | 10.5K | $0.95 | $10K |
| Jun 1, 22 | Jeffrey SegalDirector | BUY | 9.2K | $0.95 | $9K |
| Jun 1, 22 | Steve ShumChief Executive Officer | BUY | 58.9K | $0.95 | $56K |
| Jun 1, 22 | Matthew K SzotDirector | BUY | 14.5K | $0.95 | $14K |
| Oct 5, 21 | Andrea GorenChief Financial Officer | BUY | 30.7K | $3.26 | $100K |
| Oct 5, 21 | Steve ShumChief Executive Officer | BUY | 30.7K | $3.26 | $100K |
Over the past 12 months, insiders at INVO Bioscience, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on INVO, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market INVO insider purchase in our data was $168K by Kevin Doody, Medical Director, filed on Jun 1, 22.
0 different insiders at INVO Bioscience, Inc. filed open-market SEC Form 4 transactions on INVO over the last 12 months.
InsiderTape plots every INVO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every INVO Bioscience, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →